✦ LIBER ✦

Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: Case-control study in patients with multiple myeloma and review of the literature

✍ Scribed by Pellegrino Musto; Potito Rosario Scalzulli; Elisabetta Terruzzi; Fausto Rossini; Pasquale Iacopino; Giuseppe Messina; Roberto Guariglia; Giuseppe Pietrantuono; Oreste Villani; Fiorella D’Auria; Antonietta Falcone; Grazia Sanpaolo; Maria Rosa Valvano; Enrico Maria Pogliani; Fortunato Morabito

Book ID: 104040365
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 220 KB
Volume: 31
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2007.01.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN60 COST-EFFECTIVENESS OF PEGFILGRASTI

PCN60 COST-EFFECTIVENESS OF PEGFILGRASTIM VERSUS FILGRASTIM AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MYELOMA

✍ L. Perrier; A. Lefranc; P. Quittet; P. Moreau; C. Siani; H. Ghesquières; F. Jard 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Comparison of fixed dose pegfilgrastim a

Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis

✍ Felicetto Ferrara; Tiziana Izzo; Clelia Criscuolo; Cira Riccardi; Assunta Viola; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract Different authors have explored the feasibility of autografting patients with multiple myeloma (MM) on an outpatient basis. Peg‐filgrastim (PEG), a long‐acting recombinant G‐CSF, has similar efficacy when compared to conventional G‐CSF for chemotherapy‐induced neutropenia, but little is

Unusual cutaneous involvement during pla

Unusual cutaneous involvement during plasma cell leukaemia phase in a multiple myeloma patient after treatment with thalidomide: a case report and review of the literature

✍ D. T. Alexandrescu; L. Koulova; P. H. Wiernik 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

Pegfilgrastim to accelerate neutrophil e

Pegfilgrastim to accelerate neutrophil engraftment following peripheral blood stem cell transplant and reduce the duration of neutropenia, hospitalization, and use of intravenous antibiotics: a phase II study in multiple myeloma and lymphoma and comparison with filgrastim-treated matched controls

✍ Wannesson, Luciano; Luthi, François; Zucca, Emanuele; Rosselet-christ, Anne; Bag 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 282 KB

Effect of high-dose melphalan and periph

Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature

✍ E. Reiter; P. Kalhs; F. Keil; W. Rabitsch; H. Gisslinger; G. Mayer; N. Worel; K. 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 49 KB

Aprepitant for the control of delayed na

Aprepitant for the control of delayed nausea and vomiting associated with the use of high-dose melphalan for autologous peripheral blood stem cell transplants in patients with multiple myeloma: a phase II study

✍ Bechtel, Thomas; McBride, Ali; Crawford, Brooke; Bullington, Susan; Hofmeister, 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 248 KB